Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Profit After TaxShare-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Innate Pharma (IPHA) Shares Outstanding (2019 - 2025)

Historic Shares Outstanding for Innate Pharma (IPHA) over the last 6 years, with Q2 2025 value amounting to $18.9 million.

  • Innate Pharma's Shares Outstanding rose 1968.32% to $104.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $104.4 million, marking a year-over-year increase of 1968.32%. This contributed to the annual value of $90.7 million for FY2024, which is 374.96% up from last year.
  • As of Q2 2025, Innate Pharma's Shares Outstanding stood at $104.4 million, which was up 1968.32% from $89.6 million recorded in Q4 2024.
  • In the past 5 years, Innate Pharma's Shares Outstanding ranged from a high of $104.4 million in Q2 2025 and a low of $81.8 million during Q4 2022
  • Moreover, its 5-year median value for Shares Outstanding was $87.7 million (2023), whereas its average is $89.9 million.
  • Per our database at Business Quant, Innate Pharma's Shares Outstanding soared by 1418.16% in 2021 and then plummeted by 4536.91% in 2025.
  • Innate Pharma's Shares Outstanding (Quarter) stood at $66.7 million in 2021, then decreased by 11.74% to $58.9 million in 2022, then decreased by 1.54% to $58.0 million in 2023, then plummeted by 40.29% to $34.6 million in 2024, then plummeted by 45.37% to $18.9 million in 2025.
  • Its Shares Outstanding was $104.4 million in Q2 2025, compared to $89.6 million in Q4 2024 and $87.2 million in Q2 2024.